Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Breilh

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Antimicrobial Agents and Chemotherapy|August 17, 2002
Human immunodeficiency virus type 1 genotypic and pharmacokinetic determinants of the virological response to lopinavir-ritonavir-containing therapy in protease inhibitor-experienced patientsBernard Masquelier, Dominique Breilh, Didier Neau, et al.
Open Forum Infectious Diseases|June 26, 2025
Pharmacokinetics of Subcutaneous and Intravenous Ceftriaxone in an Older Population: The PhASAge StudyClaire Roubaud-Baudron, Héloïse Fauchon, Françoise Stanke-Labesque, et al.
The Journal of Antimicrobial Chemotherapy|February 22, 2012
Alveolar diffusion and pharmacokinetics of linezolid administered in continuous infusion to critically ill patients with ventilator-associated pneumoniaEmmanuel Boselli, Dominique Breilh, Aurore Caillault-Sergent, et al.
British Journal of Clinical Pharmacology|July 22, 2014
Pre-dose plasma concentration monitoring of mycophenolate mofetil in patients with autoimmune diseasesCaroline Streicher, Sarah Djabarouti, Fabien Xuereb, et al.
HIV Clinical Trials|April 17, 2007
Pravastatin in HIV-infected patients treated with protease inhibitors: a placebo-controlled randomized studyFabrice Bonnet, Valerie Aurillac-Lavignolle, Dominique Breilh, et al.
Neonatology|March 23, 2007
Efficacy and tolerance of high-dose inhaled ipratropium bromide vs. terbutaline in intubated premature human neonatesMichael Fayon, Nawar Tayara, Christine Germain, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 8, 2017
A new reliable, transposable and cost-effective assay for absolute quantification of total plasmatic bevacizumab by LC-MS/MS in human plasma comparing two internal standard calibration approachesRachel Legeron, Fabien Xuereb, Stephane Chaignepain, et al.
The Journal of Antimicrobial Chemotherapy|August 4, 2025
Intrapulmonary concentrations of ceftobiprole high doses administered by continuous infusion in critically ill patients with community-acquired pneumoniaClaire Roger, Bernard Allaouchiche, Daniel Quintão De Moraes, et al.
International Journal of Antimicrobial Agents|November 29, 2017
Association between augmented renal clearance, antibiotic exposure and clinical outcome in critically ill septic patients receiving high doses of β-lactams administered by continuous infusion: a prospective observational studyCédric Carrié, Laurent Petit, Nicolas d'Houdain, et al.
AIDS (London, England)|September 15, 2004
Virological, intracellular and plasma pharmacological parameters predicting response to lopinavir/ritonavir (KALEPHAR study)Dominique Breilh, Isabelle Pellegrin, Agnés Rouzés, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Antimicrobial Agents and Chemotherapy|August 17, 2002
Human immunodeficiency virus type 1 genotypic and pharmacokinetic determinants of the virological response to lopinavir-ritonavir-containing therapy in protease inhibitor-experienced patientsBernard Masquelier, Dominique Breilh, Didier Neau, et al.
Open Forum Infectious Diseases|June 26, 2025
Pharmacokinetics of Subcutaneous and Intravenous Ceftriaxone in an Older Population: The PhASAge StudyClaire Roubaud-Baudron, Héloïse Fauchon, Françoise Stanke-Labesque, et al.
The Journal of Antimicrobial Chemotherapy|February 22, 2012
Alveolar diffusion and pharmacokinetics of linezolid administered in continuous infusion to critically ill patients with ventilator-associated pneumoniaEmmanuel Boselli, Dominique Breilh, Aurore Caillault-Sergent, et al.
British Journal of Clinical Pharmacology|July 22, 2014
Pre-dose plasma concentration monitoring of mycophenolate mofetil in patients with autoimmune diseasesCaroline Streicher, Sarah Djabarouti, Fabien Xuereb, et al.
HIV Clinical Trials|April 17, 2007
Pravastatin in HIV-infected patients treated with protease inhibitors: a placebo-controlled randomized studyFabrice Bonnet, Valerie Aurillac-Lavignolle, Dominique Breilh, et al.
Neonatology|March 23, 2007
Efficacy and tolerance of high-dose inhaled ipratropium bromide vs. terbutaline in intubated premature human neonatesMichael Fayon, Nawar Tayara, Christine Germain, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 8, 2017
A new reliable, transposable and cost-effective assay for absolute quantification of total plasmatic bevacizumab by LC-MS/MS in human plasma comparing two internal standard calibration approachesRachel Legeron, Fabien Xuereb, Stephane Chaignepain, et al.
The Journal of Antimicrobial Chemotherapy|August 4, 2025
Intrapulmonary concentrations of ceftobiprole high doses administered by continuous infusion in critically ill patients with community-acquired pneumoniaClaire Roger, Bernard Allaouchiche, Daniel Quintão De Moraes, et al.
International Journal of Antimicrobial Agents|November 29, 2017
Association between augmented renal clearance, antibiotic exposure and clinical outcome in critically ill septic patients receiving high doses of β-lactams administered by continuous infusion: a prospective observational studyCédric Carrié, Laurent Petit, Nicolas d'Houdain, et al.
AIDS (London, England)|September 15, 2004
Virological, intracellular and plasma pharmacological parameters predicting response to lopinavir/ritonavir (KALEPHAR study)Dominique Breilh, Isabelle Pellegrin, Agnés Rouzés, et al.
Pageof 6